Potential Considerations Though GLP-1 medications are generally well-tolerated, some individuals may experience: Mild nausea or digestive discomfort (typically improving over time) Temporary fatigue during dose adjustment Injection site reactions Changes in taste preferences Slight risk of more serious side effects (rare) Conclusion As medical weight management evolves, GLP-1 medications stand at the forefront, offering hope to those struggling with conventional weight loss methods
Molecular Biology of the Cell, 9 (1), 114
Women are twice as likely to have side-effects when taking GLP-1 receptor agonists including gastrointestinal symptoms like vomiting
The FDA investigation into AC and GLP-1 RA drugs reported: The median age for people who developed AC was 55 years old Of the people who developed AC, 53% were female After starting the drug, 47% of patients developed AC within 90 days Cholelithiasis, or gallstones, was also added to the approval label
Reagents and general procedures from the Gibson assembly cloning kit from New England Biolabs (NEB) were used